Michael J. Birrer - Publications, H-index & Citations

Back

Michael J. Birrer

University of Arkansas System

126H-index

1.1KPaper Count

10.4WCitation Count

Published Papers 197

Publication Date

An alternative perspective on the Functional Assessment of Chronic Illness Therapy-Spiritual Well-Being 12 item Scale (FACIT-Sp-12) in people newly diagnosed with advanced cancer

JOURNAL OF PSYCHOSOCIAL ONCOLOGY

IF1.5

2025-11-01

PREAI

Bai, Mei; Cella, David; Jeon, Sangchoon; Govindarajan, Rang; Birrer, Michael J.

Save

Safety and efficacy of mirvetuximab soravtansine, a folate receptor alpha (FRα)–targeting antibody-drug conjugate (ADC), in combination with pembrolizumab in patients with platinum-resistant ovarian cancer

gynecologic oncology

IF4.1

2025-07-22

PREAI

Ursula A. Matulonis; Ignace Vergote; Kathleen N. Moore; Lainie P. Martin; Cesar M. Castro; Lucy Gilbert; Yu Xia; Michael Method; James Stec; Michael J. Birrer; David M. O'Malley

Save

Single-cell analysis of ovarian myeloid cells identifies age-associated changes in macrophages and signaling dynamics†

BIOLOGY OF REPRODUCTION

IF3

2025-06-01

PREAI

Zhang, Zijing; Huang, Lu; Brayboy, Lynae; Birrer, Michael

Save

Metabolically active neutrophils represent a permissive niche for Mycobacterium tuberculosis

MUCOSAL IMMUNOLOGY

IF7.6

2024-10-01

OAAI

Andrews, J. Tucker; Zhang, Zijing; Prasad, G. V. R. Krishna; Huey, Fischer; Nazarova, Evgeniya, V; Wang, Jocelyn; Ranaraja, Ananya; Weinkopff, Tiffany; Li, Lin-Xi; Mu, Shengyu; Birrer, Michael J.; Huang, Stanley Ching-Cheng; Zhang, Nan; Argueello, Rafael J.; Philips, Jennifer A.; Mattila, Joshua T.; Huang, Lu

Save

CAF-derived MFAP5 enhances immune escape through up-regulating immune checkpoint mediator CD47 in ovarian cancer cells and CD8+T cells

CANCER RESEARCH

IF16.6

2024-03-04

PREAI

Ferri-Borgogno, Sammy; Yeung, Tsz-Lun; York, Emily; Talor, Marina; Pacheco, Yadira; Nurieva, Roza; Birrer, Michael; Mok, Samuel

Save

Overcoming adaptive resistance to anti-VEGF therapy by targeting CD5L

NATURE COMMUNICATIONS

IF15.7

2023-04-26

OAAI

LaFargue, Christopher J.; Amero, Paola; Noh, Kyunghee; Mangala, Lingegowda S.; Wen, Yunfei; Bayraktar, Emine; Umamaheswaran, Sujanitha; Stur, Elaine; Dasari, Santosh K.; Ivan, Cristina; Pradeep, Sunila; Yoo, Wonbeak; Lu, Chunhua; Jennings, Nicholas B.; Vathipadiekal, Vinod; Hu, Wei; Chelariu-Raicu, Anca; Ku, Zhiqiang; Deng, Hui; Xiong, Wei; Choi, Hyun-Jin; Hu, Min; Kiyama, Takae; Mao, Chai-An; Ali-Fehmi, Rouba; Birrer, Michael J.; Liu, Jinsong; Zhang, Ningyan; Lopez-Berestein, Gabriel; de Franciscis, Vittorio; An, Zhiqiang; Sood, Anil K.

Save

AP1 regulation of proliferation and initiation of apoptosis in erythropoietin-dependent erythroid cells

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-28

OAAI

Jacobs-Helber, SM; Wickrema, A; Birrer, MJ; Sawyer, ST

Save

Tumor necrosis factor alpha gene regulation:: Enhancement of C/EBPβ-induced activation by c-Jun

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-28

108

OAAI

Zagariya, A; Mungre, S; Lovis, R; Birrer, M; Ness, S; Thimmapaya, B; Pope, R

Save

Jun blockade of erythropoiesis: Role for repression of GATA-1 by HERP2

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-27

OAAI

Elagib, KE; Xiao, M; Hussaini, IM; Delehanty, LL; Palmer, LA; Racke, FK; Birrer, MJ; Shanmugasundaram, G; McDevitt, MA; Goldfarb, AN

Save

p75-Ras-GRF1 is a c-Jun/AP-1 target protein: Its up regulation results in increased ras activity and is necessary for c-Jun-induced nonadherent growth of Rat1a cells

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-27

OAAI

Leaner, VD; Donninger, H; Ellis, CA; Clark, GJ; Birrer, MJ

Save

Jun Blockade of Erythropoiesis: Role for Repression of GATA-1 by HERP2 (vol 24, pg 7779, 2004)

MOLECULAR AND CELLULAR BIOLOGY

IF2.7

2023-03-20

OAAI

Elagib, Kamaleldin E.; Xiao, Mang; Hussaini, Isa M.; Delehanty, Lorrie L.; Palmer, Lisa A.; Racke, Frederick K.; Birrer, Michael J.; Ganapathy-Kanniappan, Shanmugasundaram; McDevitt, Michael A.; Goldfarb, Adam N.

Save

LINE-1 ORF1p as a candidate biomarker in high grade serous ovarian carcinoma

SCIENTIFIC REPORTS

IF3.9

2023-01-27

OAAI

Sato, Sho; Gillette, Michael; de Santiago, Pamela R.; Kuhn, Eric; Burgess, Michael; Doucette, Kristen; Feng, Yi; Mendez-Dorantes, Carlos; Ippoliti, Paul J.; Hobday, Sara; Mitchell, Marilyn A.; Doberstein, Kai; Gysler, Stefan M.; Hirsch, Michelle S.; Schwartz, Lauren; Birrer, Michael J.; Skates, Steven J.; Burns, Kathleen H.; Carr, Steven A.; Drapkin, Ronny

Save

Targeting NaPi2b in ovarian cancer

CANCER TREATMENT REVIEWS

IF10.5

2023-01-01

PREAI

Banerjee, Susana; Drapkin, Ronny; Richardson, Debra L.; Birrer, Michael

Save

Exposure response (ER) analysis for efficacy and safety of mirvetuximab soravtansine (MIRV) in patients with folate receptor α (FRα)-positive cancer

ANNALS OF ONCOLOGY

IF65.4

2022-09-01

OAAI

Matulonis, U. A.; Moore, K. N.; Lorusso, D.; Oaknin, A.; Pignata, S.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J.; Marin, M. Romeo; Harter, P.; Murphy, C.; Tu, Y.; Zhu, F.; Esteves, B.; Method, M.; Birrer, M. J.; Coleman, R. L.; O'Malley, D.

Save

Population pharmacokinetic (PK) analysis of mirvetuximab soravtansine (MIRV) in patients with folate receptor α (FRα)-positive cancer

ANNALS OF ONCOLOGY

IF65.4

2022-09-01

OAAI

Moore, K. N.; Lorusso, D.; Oaknin, A.; Pignata, S.; Denys, H.; Colombo, N.; Van Gorp, T.; Konner, J.; Romeo Marin, M.; Harter, P.; Murphy, C.; Tu, Y.; Zhu, F.; Esteves, B.; Method, M.; Birrer, M. J.; Coleman, R. L.; Matulonis, U. A.; O'Malley, D.

Save

The Changing Landscape of Systemic Treatment for Cervical Cancer: Rationale for Inhibition of the TGF-β and PD-L1 Pathways

FRONTIERS IN ONCOLOGY

IF3.3

2022-02-23

OAAI

Birrer, Michael J.; Fujiwara, Keiichi; Oaknin, Ana; Randall, Leslie; Ojalvo, Laureen S.; Valencia, Christian; Ray-Coquard, Isabelle

Save

Utilization of a 3-D tissue engineered model to investigate the effects of perfusion on gynecologic cancer biology

JOURNAL OF TISSUE ENGINEERING

IF7

2021-11-17

OAAI

Martinez, Alba; Buckley, Molly S.; Scalise, Carly B.; Wang, Dezhi; Katre, Ashwini A.; Birrer, Michael J.; Berry, Joel L.; Arend, Rebecca C.

Save

A highly annotated database of genes associated with platinum resistance in cancer

ONCOGENE

IF7.3

2021-10-13

OAAI

Huang, Dongqing; Savage, Sara R.; Calinawan, Anna P.; Lin, Chenwei; Zhang, Bing; Wang, Pei; Starr, Timothy K.; Birrer, Michael J.; Paulovich, Amanda G.

Save

Association of homologous recombination deficiency (HRD) with clinical outcomes in a phase III study of olaparib or cediranib and olaparib compared to platinum-based chemotherapy in recurrent platinum-sensitive ovarian cancer (PSOC): Biomarker analyses from NRG-GY004

ANNALS OF ONCOLOGY

IF65.4

2021-09-01

OAAI

Swisher, E.; Miller, A.; Kohn, E.; Brady, M.; Radke, M.; Pennil, C.; Khasnavis, N.; Buscema, J.; Tew, W.; Muller, C.; Hill, E.; Moore, R.; Michelin, D.; Waggoner, S.; Geller, M.; Fujiwara, K.; D'Andre, S.; Liu, J.; Birrer, M. J.

Save

Phase III, randomized trial of mirvetuximab soravtansine versus chemotherapy in patients with platinum-resistant ovarian cancer: primary analysis of FORWARD I

ANNALS OF ONCOLOGY

IF65.4

2021-06-01

148

OAAI

Moore, K. N.; Oza, A. M.; Colombo, N.; Oaknin, A.; Scambia, G.; Lorusso, D.; Konecny, G. E.; Banerjee, S.; Murphy, C. G.; Tanyi, J. L.; Hirte, H.; Konner, J. A.; Lim, P. C.; Prasad-Hayes, M.; Monk, B. J.; Pautier, P.; Wang, J.; Berkenblit, A.; Vergote, I; Birrer, M. J.

Save

Research Directions